CN1150021A - 清肠剂 - Google Patents

清肠剂 Download PDF

Info

Publication number
CN1150021A
CN1150021A CN 96116215 CN96116215A CN1150021A CN 1150021 A CN1150021 A CN 1150021A CN 96116215 CN96116215 CN 96116215 CN 96116215 A CN96116215 A CN 96116215A CN 1150021 A CN1150021 A CN 1150021A
Authority
CN
China
Prior art keywords
clearing agent
bowel clearing
bowel
chloride
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 96116215
Other languages
English (en)
Inventor
李智军
卜国平
詹尚书
张全英
高志昕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 96116215 priority Critical patent/CN1150021A/zh
Publication of CN1150021A publication Critical patent/CN1150021A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种清肠剂,它主要由聚乙二醇和氯化钠、氯化钾、碳酸氢钠、无水硫酸钠等组成,该清肠剂既能干净地清除肠内物质,又对人体没有副作用和不适感,而且在检查时造影清晰。

Description

清肠剂
本发明涉及一种清肠药物。
消化道疾病的诊断,需做各种造影,如X光钡透、内窥镜检查、X光检查结肠,腹腔手术前检查,而造影前必须用清肠剂予以清肠;过去常用的清肠剂有甘露醇、硫酸镁、番泻叶等,虽有一定效果,但也有一定的副作用,如甘露醇服用后会引起体内脱水,使血液浓度增加,对某些心脏病人会产生不良后果,同时,甘露醇在体内还会分解后产生氢气,在作内窥镜通电检查治疗时,有引起爆炸的危险;番泻叶服用后使肠蠕动增加,容易发生肠痉挛疼痛,粘膜呈充血反应,由于痉挛性疼痛使肠内物质清除不干净。
本发明的目的是:提供一种清肠剂,它既能干净地清除肠内物质,又对人体没有副作用和不适感,而且在检查时造影清晰。
本发明的技术方案是:
一种清肠剂,其配方包括下列成份:
(1).聚乙二醇  28--36;
(2).电解质    4--6。
本发明进一步的技术方案是:
一种清肠剂,其配方包括下列成份:
(1).聚乙二醇  28--36;
(2).氯化钠    0.66--0.8;
(3).氯化钾    0.335--0.415;
(4).碳酸氢钠  0.76--0.92;
(5).无水硫酸钠2.5--3.1。
本发明的优点是:
1.由于本发明采用了无毒和肠胃不吸收的聚乙二醇为原料,加上电介质氯化钠、氯化钾、碳酸氢钠、无水硫酸铜组成,所以在有极好的清肠作用,且能维持体液的等渗,所以在服用后能将肠内物质清泻干净,无任何不适感和副作用。
2.由于要本发明服用后不失水,不使电解质吝乱,所以对粘膜不会造成充血,所以对年老体弱者及怀孕妇女都能适用,对任何患者均无禁忌,还可以作为严重便秘者有效的导泻药。
下面结合实施例对本发明作进一步的描述:
实施例:一种清肠剂,采用下列配方:
(1).聚乙二醇   32;
(2).氯化钠     0.73;
(3).氯化钾     0.375;
(4).碳酸氢钠   0.84;
(5).无水硫酸钠 2.84。
采用下列工艺:
将聚乙二醇冷冻干燥后打成细粉,将氯化钠、氯化钾、碳酸氢钠、无水硫酸钠打成细粉,然后混合均匀;服用时,将药粉加温开水,溶解后口服。

Claims (2)

1.一种清肠剂,其配方包括下列成份:
(1).聚乙二醇  28--36;
(2).电解质    4--6。
2.根据权利要求1所述的清肠剂,其特征在于:所述电解质的配方包括下列成份:
(1).氯化钠     0.66--0.8;
(2).氯化钾     0.335--0.415;
(3).碳酸氢钠   0.76--0.92;
(4).无水硫酸钠 2.5--3.1。
CN 96116215 1996-01-11 1996-01-11 清肠剂 Pending CN1150021A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96116215 CN1150021A (zh) 1996-01-11 1996-01-11 清肠剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96116215 CN1150021A (zh) 1996-01-11 1996-01-11 清肠剂

Publications (1)

Publication Number Publication Date
CN1150021A true CN1150021A (zh) 1997-05-21

Family

ID=5123337

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96116215 Pending CN1150021A (zh) 1996-01-11 1996-01-11 清肠剂

Country Status (1)

Country Link
CN (1) CN1150021A (zh)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389779C (zh) * 2006-07-07 2008-05-28 北京昭衍博纳新药研究有限公司 一种用于肠道清洁的药物组合物
CN102772427A (zh) * 2012-08-20 2012-11-14 深圳万和制药有限公司 一种复方聚乙二醇电解质组合物
CN102805753A (zh) * 2012-08-20 2012-12-05 深圳万和制药有限公司 包含聚乙二醇和电解质的药物组合物
CN102805752A (zh) * 2012-08-20 2012-12-05 深圳万和制药有限公司 复方聚乙二醇电解质散及其制备方法
CN103393808A (zh) * 2013-08-19 2013-11-20 王志英 一种用于孕后期引产前清肠的药物
CN103989701A (zh) * 2014-05-12 2014-08-20 中国人民解放军第二军医大学 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用
US8999313B2 (en) 2012-09-11 2015-04-07 Norgine Bv Compositions
US9592252B2 (en) 2011-03-11 2017-03-14 Norgine Bv Colonoscopy—preparation
CN112472718A (zh) * 2020-12-01 2021-03-12 唐传生物科技(厦门)有限公司 改善口服清肠或肠道准备剂电解质紊乱副作用的组合物

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389779C (zh) * 2006-07-07 2008-05-28 北京昭衍博纳新药研究有限公司 一种用于肠道清洁的药物组合物
US9592252B2 (en) 2011-03-11 2017-03-14 Norgine Bv Colonoscopy—preparation
US11529368B2 (en) 2011-03-11 2022-12-20 Norgine Bv Colonoscopy—preparation
US10792306B2 (en) 2011-03-11 2020-10-06 Norgine Bv Colonoscopy—preparation
US10780112B2 (en) 2011-03-11 2020-09-22 Norgine Bv Colonoscopy-preparation
US10646512B2 (en) 2011-03-11 2020-05-12 Norgine Bv Colonoscopy - preparation
CN102772427B (zh) * 2012-08-20 2014-02-05 深圳万和制药有限公司 一种复方聚乙二醇电解质组合物
CN102805752B (zh) * 2012-08-20 2014-04-02 深圳万和制药有限公司 复方聚乙二醇电解质散及其制备方法
CN102772427A (zh) * 2012-08-20 2012-11-14 深圳万和制药有限公司 一种复方聚乙二醇电解质组合物
CN102805753A (zh) * 2012-08-20 2012-12-05 深圳万和制药有限公司 包含聚乙二醇和电解质的药物组合物
CN102805752A (zh) * 2012-08-20 2012-12-05 深圳万和制药有限公司 复方聚乙二醇电解质散及其制备方法
US9326969B2 (en) 2012-09-11 2016-05-03 Norgine Bv Compositions
US9707297B2 (en) 2012-09-11 2017-07-18 Norgine Bv Compositions
US10016504B2 (en) 2012-09-11 2018-07-10 Norgine Bv Compositions
US10918723B2 (en) 2012-09-11 2021-02-16 Norgine Bv Colon cleansing compositions and methods of use
US8999313B2 (en) 2012-09-11 2015-04-07 Norgine Bv Compositions
CN103393808A (zh) * 2013-08-19 2013-11-20 王志英 一种用于孕后期引产前清肠的药物
CN103393808B (zh) * 2013-08-19 2015-09-09 王志英 一种用于孕后期引产前清肠的药物
CN103989701A (zh) * 2014-05-12 2014-08-20 中国人民解放军第二军医大学 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用
CN112472718A (zh) * 2020-12-01 2021-03-12 唐传生物科技(厦门)有限公司 改善口服清肠或肠道准备剂电解质紊乱副作用的组合物

Similar Documents

Publication Publication Date Title
Bassotti et al. Colonic mass movements in idiopathic chronic constipation.
JP2774106B2 (ja) 下剤水溶液
CN1150021A (zh) 清肠剂
Andreoni et al. Emergency management of caustic ingestion in adults
Cohen et al. Acute suppurative parotitis with spread to the deep neck spaces
Connell Applied physiology of the colon: factors relevant to diverticular disease
CN1026464C (zh) 一种肛门栓剂的制备工艺
CN112870382B (zh) 阿拉伯糖和硅油类消泡剂联合用于肠道准备
Saw et al. Ileocaecal Perforation and Bleeding-Are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Responsible?
Halata et al. Gardner Syndrome: Early Presentation with a Desmoid Tumor: Discovery of Multiple Colonic Polyps.
KR20010029068A (ko) 죽염과 운모를 유효성분으로 함유하는 질정제
RU2817173C1 (ru) Способ эндоскопического гемостаза кровоточащих полипов желудочно-кишечного тракта
Edlich et al. Wangensteen's transformation of the treatment of intestinal obstruction from empiric craft to scientific discipline
SU1537262A1 (ru) Способ лечени хронических колитов
CN1088378C (zh) 治疗慢性浅表性胃炎的中药口服液及其制备方法
Babb et al. Recurrent appendicitis: uncommon, but it does occur
CN1054776C (zh) 胃肠b超快速显像剂
SU1158164A1 (ru) Способ лечени острой тонкокишечной непроходимости
Punto et al. Effect of acid on the motility of the oesophagus of the pig with experimentally induced oesophagitis
Park et al. Stercoral ulcer due to chicken bones in rectum: overtube used as a conduit for endoscopic removal
CN117100764A (zh) 一种用于胶囊内镜检查前的组合物
임한솔 et al. A case of asymptomatic colonic perforation after endoscopic biopsy of a submucosal lesion
Tandi et al. Corpus Alienum Esophagus (Denture) with Proximal Esophageal Perforation Complications
OIKAWA et al. A CASE OF PNEUMATOSIS CYTOIDES INTESTINALIS
Means Remarks on Chronic Ailments of the Colon

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication